Facilitating Review of Real-World Data Studies: The Oncology QCARD Initiative
By Donna R. Rivera PharmD MS & Paul G. Kluetz MD – Expanding ways to generate evidence can lead to an array of benefits for medical product development, including more diverse patient representation and the potential to expedite the availability of safe and effective therapies.
